XtalPi Holdings Rises Near 4-Month High as Chairman Plans Share Buy
Shares of XtalPi Holdings gained 7.9% to HK$8.655, their highest level since May 29, on Thursday, on track for a third straight session of gains and ranking as the fifth-biggest percentage gainer in the Hang Seng Biotech Index. The company's chairman and co-founder, Wen Shuhao, intends to acquire shares in the open market by the end of October using his own funds, up to HK$32 million ($4.08 million), a move the board believes reflects confidence in the company's long-term development prospects.
Shares of XtalPi Holdings rise 7.9% to HK$8.655, their highest level since May 29. The stock is on course for a third straight session of gains and is the fifth biggest percentage gainer in the Hang Seng Biotech Index, which is up 4.8%. The Hong Kong-listed drug and material science R&D solutions provider said its chairman and co-founder Wen Shuhao intends to buy shares in the open market by end-October using his own funds of up to HK$32 million ($4.08 million). The board said the planned increase in Wen's shareholding reflects his confidence in the company's long-term development prospects and value.
Year to date, the stock is down 9.6%, while the benchmark Hang Seng Index is down 2.9%. ($1 = 7.8448 Hong Kong dollars)